8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 19, 2016
CALUMET SPECIALTY PRODUCTS PARTNERS, L.P.
(Exact name of registrant as specified in its charter)
|
| | | | |
| | | | |
DELAWARE
(State or other jurisdiction
of incorporation) | | 000-51734
(Commission File Number) | | 37-1516132
(IRS Employer
Identification No.) |
2780 Waterfront Pkwy E. Drive
Suite 200
Indianapolis, Indiana 46214
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (317) 328-5660
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| |
Item 7.01 | Regulation FD Disclosure. |
On January 19, 2016, Calumet Specialty Products Partners, L.P. (the “Partnership”) issued a press release providing a business update and announcing that the Board of Directors of Calumet GP, LLC, the general partner of the Partnership, declared a cash distribution for the quarter ended December 31, 2015 of $0.685 per common unit, or $2.74 on an annualized basis. The distribution will be paid on February 12, 2016 to unitholders of record as of the close of business on February 2, 2016. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
This press release is being furnished pursuant to General Instruction B.2 of Form 8-K and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor is it subject to the liabilities of that section or deemed incorporated by reference into any filing made by the Partnership under the Exchange Act and the Securities Act of 1933, as amended.
| |
Item 9.01 | Financial Statements and Exhibits. |
|
| | |
Exhibit Number | | Description |
99.1 | | Press Release, dated January 19, 2016. |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| |
| CALUMET SPECIALITY PRODUCTS PARTNERS, L.P.
|
| By: CALUMET GP, LLC, its General Partner |
| |
Date: January 19, 2016 | By: /s/ R. Patrick Murray, II |
| Name: R. Patrick Murray, II
Title: Executive Vice President, Chief Financial Officer and Secretary |
Exhibit Index
|
| | |
Exhibit Number | | Description |
99.1 | | Press Release, dated January 19, 2016. |